SBIR Phase I: Nanogel Stabilized Biocatalysts for Enabling Real-Time Biochemical Oxygen Demand Tests

SBIR 第一阶段：纳米凝胶稳定生物催化剂，用于实现实时生化需氧量测试

• 批准号: 0946086
• 负责人: Ross Thomas
• 金额: $ 15万
• 依托单位: SyntroTek Corporation
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-01-01 至 2010-12-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=0946086&HistoricalAwards=false
• 关键词: SBIR; Phase; Nanogel; Stabilized; Biocatalysts

This SBIR Phase I project will develop a nanogel stabilized biocatalyst for the measurement of biochemical oxygen demand (BOD). If successful, this test would take less than 10 minutes, be automated, and would result in a substantial decrease in cost.The broader/commercial impact of the project will be that BOD tests are performed by many municipal and industrial wastewater treatment plants and therefore this project, focusing on the development of a rapid BOD test, could have a large impact.

这个SBIR一期项目将开发一种纳米凝胶稳定的生物催化剂，用于测量生化需氧量（BOD）。如果成功，该测试将花费不到10分钟的时间，是自动化的，并且将导致成本的大幅降低。该项目的更广泛/商业影响将是，许多市政和工业废水处理厂进行了生物需氧量测试，因此，该项目侧重于开发快速生物需氧量测试，可能会产生重大影响。